Glaxo Wellcome S/A is a finished-dose manufacturer based in Spain. It appears in 162 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with ANVISA (Brazil), ARCSA (EC) and MINSA (CR). Its GMP standing is certified by MFDS (Korea), EMA and NAFDAC (NG), among 5 authorities.
| Site | FDA FEI |
|---|---|
| Aranda De Duero(Burgos), United Arab Emirates | Not on file |
| Burgos, Spain | Not on file |
| ARANDA DE DUERO, Spain | Not on file |
| Aranda De Duero, Spain | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ANVISA (Brazil) | 129 | None |
| ARCSA (EC) | 13 | None |
| MINSA (CR) | 9 | None |
| INVIMA (CO) | 7 | None |
| NAFDAC (NG) | 2 | 1 |
| COFEPRIS (MX) | 1 | None |
| MFDS (Korea) | None | 2 |
| EMA | None | 1 |
| NCELS (KZ) | None | 1 |
| AEMPS (ES) | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Glaxo Wellcome S/A comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.